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Shigella dysentery, typhoid fever and the plague are diseases that affect 
more than 20 million people per year. Understanding the disease 
mechanism could open the door to inexpensive treatments for these 
diseases, which affect mainly developing countries. The bacterial 
species that cause these life-threatening diseases require a TTSS to deliver 
virulence factors. TTSSs consist of a multiannular base crossing both 
bacterial membranes and an extracellular needle-shaped structure1–9. 
The major needle component—YscF, PrgI and MxiH in Yersinia 
 enterocolitica, S. typhimurium and S. flexneri, respectively—is a small 
protein (protomer) that is conserved among TTSSs10 (Supplementary 
Fig. 1). Recent studies in Y. enterocolitica2 and S. typhimurium11  
elegantly show that TTSS proteins that interact with the protomer 
control the length of the growing needle. However, the protomer 
could not be investigated in detail due to its spontaneous polymeri-
zation. To advance our understanding of this huge macromolecular 
system, it is essential to analyze its assembly mechanism. Here we 
address the questions of how the soluble cytosolic protomers switch 
into a polymerization-competent state and to which end of the needle 
these proteins are attached during growth12–15.
RESULTS
Design	of	a	functional	and	soluble	needle	protomer	mutant
Thus far, biophysical and biochemical studies of TTSS needles have used 
C-terminally truncated protomers that were soluble but nonfunctional. 
In a systematic mutagenesis screen, we identified a mutant that is soluble 
when expressed heterologously in Escherichia coli (Fig. 1a). This mutant 
carries modifications in two conserved residues near the C terminus 
(Val65 and Val67, referring to the PrgI sequence from S. typhimurium in 
Supplementary Fig. 1). Notably, this V65A V67A double mutant (prgI*) 
is fully functional, as it complements a prgI knockout in S. typhimurium 
(ΔprgI) as efficiently as wild-type prgI in secretion (data not shown) and 
epithelial cell invasion assays (Fig. 1b).
Polymerization	of	purified	TTSS	needle	protomer	mutants
Notably, purified PrgI* and its homolog MxiH* from S. flexneri 
spontaneously polymerize, forming a gel at high concentrations 
(Supplementary Fig. 2). PrgI* assembles into nonamyloid filaments, 
as shown by weak enhancement of thioflavin T fluorescence16 during 
polymerization and X-ray fiber diffraction experiments17 of in vitro 
needles lacking the 4.7-Å peak that is typical for cross–β-structures 
(Supplementary Fig. 3). Transmission electron microscopy (TEM) 
revealed that needle protomers form defined spicular structures 
(Fig. 1c and Supplementary Fig. 4) 10–13 nm in diameter. This 
diameter corresponds to that of TTSS needles of S. typhimurium 
 analyzed by cryo–electron microscopy8,18, supporting the function-
ality of protomer mutants. Purified PrgI* or MxiH* polymerize into 
very long needles (several μm in length instead of 50–70 nm for native 
needles; Fig. 1c and Supplementary Fig. 4) similar to reconstituted 
TTSS needles from Pseudomonas aeruginosa19. In agreement with 
recent reports in vivo, these results suggest that the needle length 
may be controlled by specific proteins, such as PrgJ8 and InvJ20 in 
S. typhimurium or YscP in Y. enterocolitica11.
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The assembly of TTSS needles in vitro can be divided in two steps, 
nucleation and elongation21. We analyzed the kinetics of PrgI* poly-
merization to determine the rate-limiting step using dynamic light 
scattering (DLS). With this method, we measured the volume fractions 
of the monomer and the growing needle. In this process, a lag phase 
was followed by needle growth in conjunction with a rapid decrease in 
free protomer concentration (Fig. 1d). The kinetic behavior indicates 
that nucleation is the rate-limiting step in PrgI* needle formation and 
might be indicative of the behavior of the wild-type protein.
Elongation	of	the	TTSS	needle	in vitro
It is not known whether, during in vivo TTSS assembly, the newly 
synthesized protomers are transported through the growing needle to 
the distal end or are incorporated at the proximal end22. To test this, 
we mixed isolated TTSSs from either S. typhimurium or S. flexneri (see 
Online Methods) with purified protomer PrgI* or MxiH*, respectively. 
Addition of the autologous protomer elongated TTSS needles sub-
stantially (Fig. 2a,b), to more than 5 μm in average length (Fig. 2c). 
TTSSs without protomer addition showed particles of constant length 
only (Fig. 2c). These results show the structural compatibility of the 
mutated and autologous protomers. We observed that the assembly 
is directional, as each elongated needle emerged from a single TTSS 
(Fig. 2b, enlarged images). Notably, we did not observe needle elon-
gation after the addition of the heterologous protomer to purified 
TTSSs (S. typhimurium with MxiH* and S. flexneri with PrgI*, data 
not shown). Consistently, S. typhimurium or S. flexneri, which were 
genetically complemented with the heterologous protomer, did not 
form needles and were unable to restore host invasion23. These experi-
ments suggest that there is a structural incompatibility of needle 
proteins and TTSSs from different bacteria, in agreement with electro-
static differences in protomer surfaces found by previous work23.
We tested the in vitro needle elongation by adding capping proteins 
such as IpaD, which forms the tip of the TTSS in S. flexneri13,15. We 
reasoned that, if needle elongation reflected a physiological process, the 
addition of these capping proteins should arrest needle growth. Indeed, 
whereas incubation of TTSS isolated from S. flexneri with MxiH* 
yielded an average needle length of 5 μm, TTSS incubated with both 
MxiH* and IpaD had an average needle length of 1 μm (Fig. 2c).
Isolated TTSS was most likely to grow in the absence of ATP or any other 
energy source, indicating that secreted PrgI* and MxiH* assemble spon-
taneously at the distal end. Therefore, it is likely that the unfolding in the 
cytoplasm and transport of the protomer through the needle require energy 
in vivo24, but the assembly does not. Taken together, these in vitro experi-
ments examining needle elongation support the model of a distal addition 
of the protomer to the needle and are consistent with reports showing that 
the structurally related flagellum is also elongated at the distal end22.
X-ray	crystal	and	solution-state	NMR	structure	of	PrgI*
To further understand the polymerization of the protomer during 
needle formation, we analyzed the structure of PrgI* in solution and 
in needles. Purified PrgI* is predominantly α-helical and monomeric 
in solution, as proven by circular dichroism and analytical ultra-
centrifugation (Supplementary Fig. 5). X-ray crystallography showed 
that residues starting from Gly19 to the C terminus of PrgI* adopt 
an α-helical hairpin conformation (Fig. 3a and Table 1). ESI-MS 
showed that crystallized PrgI* was not proteolytically degraded, 
indicating multiple conformations of the N-terminal 18 residues in 
the crystal. The ensemble of 25 NMR solution structures (Table 2, 
Supplementary Fig. 6a, representative NMR structure in Fig. 3a and 
HSQC spectrum in Supplementary Fig. 7) show a defined N termi-
nus of the protomer, resulting in structural information for residues 
Trp5–Arg80 (r.m.s. deviation of 0.56 Å for Cα atoms). In solution, 











































































Figure 1 Polymerization of a functional TTSS protomer. (a) SDS-PAGE 
of PrgI, PrgI*, MxiH and MxiH* expressed in E. coli. Double mutants were 
detected in soluble (SN) and insoluble (P) fractions, whereas wild-type 
protomer was almost insoluble (arrow). (b) Epithelial cell invasion 
assay showed wild type activity of S. typhimurium protomer knockouts 
complemented with either wild-type gene (pprgI) or protomer mutant 
(pprgI*). Percent bacterial invasion is logarithmically scaled. Deletion 
(pprgI ΔC5) or fusion (pprgI ΔC-His) of residues at the PrgI C terminus, as 
well as deletion of the N-terminal eight residues (pprgI ΔN8), abolished  
cell invasion. (c) TEM image of negatively stained needles formed in vitro 
by purified PrgI* (scale bar, 200 nm). (d) Time-dependent monomer 
conversion of PrgI* (solid line) versus needle growth (dashed line) 
monitored by DLS. Arrow, end of the lag phase.
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TTSSs. typhimurium + PrgI*


























Figure 2 In vitro assembly of TTSS needles. (a) Purified PrgI* was 
incubated with isolated TTSS (arrow) from S. typhimurium and analyzed 
by TEM (scale bar, 0.1 μm). (b) TTSS from an S. flexneri strain were 
incubated with purified MxiH* and visualized (scale bar, 1 μm). Lower 
images show enlarged regions (scale bar, 0.1 μm). (c) Length of needles 
of isolated TTSS from S. flexneri without addition of purified protomer and 
of elongated needles obtained after incubation of TTSS from S. flexneri 
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Asp11–Thr18, showing an extension of the N-terminal helix 
 compared to that of the crystal structure. The core regions (residues 
Gly19–Lys37 and Ala42–Tyr57) of the NMR and X-ray structures 
superimpose well (Supplementary Fig. 6b), with an r.m.s. deviation 
of 0.77 Å for Cα atoms. The two structures show slightly different 
helical conformations at the C terminus, which might be explained 
by crystal packing. Notably, chemical-shift deviations from random 
coil values (secondary chemical shifts) for Cα nuclei of PrgI* sug-
gest a reduced α-helix propensity outside of the core region defined 
above (Supplementary Fig. 8). These deviations can be explained by 
a higher flexibility of residues Asp11–Thr18 in the N-terminal α-helix 
and Gln61–Asn78 in the C-terminal α-helix of PrgI*. Overall, the struc-
tures indicate that the C terminus of PrgI* is α-helical, including the 
last five residues, and that the N terminus is flexible.
Mutational analysis shows that the six N-terminal residues of PrgI 
were dispensable for TTSS function, as determined by host-cell inva-
sion (prgI plasmids (pprgI) pprgI ΔN6 and pprgI ΔN8 in Fig. 1a). 
In contrast, the C terminus of PrgI is required for needle formation 
and invasion (pprgI ΔC5 and pprgI ΔC-His in Fig. 1a), as already 
reported23,25–28. Previous structural studies of different TTSS needle 
protomers using NMR23,27 or X-ray crystallography29 were limited to 
C-terminal truncation mutants. These data show that the crystal and 
NMR structures presented here are the first ones29,30 to our knowledge 
of a functional TTSS needle construct (PrgI*) before polymerization, 
as opposed to previous studies (Supplementary Fig. 9). This structure 
may reflect the conformation of the protomer in the cytosol.
PrgI*	polymerization	is	coupled	with	a	conformational	change
To detect conformational changes in the protomer upon attachment to the 
needle, we recorded time-dependent Fourier transform infrared (FTIR) 
spectra of purified PrgI* (Fig. 3b). The α-helical character of the protomer 
before polymerization is shown by the amide-I band at 1,655 cm−1 (ref. 31) 
(downward arrow in Fig. 3b). The time-resolved difference spectra showed 
a decrease of the amide-I band intensity as well as two increasing bands 
indicative of β-strand formation at 1,617 cm−1 and 1,694 cm−1 (upward 
arrows in Fig. 3b). Thus, a backbone α-helix–to–β-strand conversion31 
in PrgI* affecting ~20% of the residues occurs simultaneously with the 
polymerization process (see Supplementary Methods).
C	terminus	of	polymerized	PrgI*	adopts	b-strand	conformation
To locate the residues involved in the α-helix–to–β-strand conversion, the 
structure of PrgI* within the needle was probed with magic-angle spinning 
(MAS) solid-state NMR spectroscopy (ssNMR). Multidimensional corre-
lation spectra confirmed α-helical and random-coil secondary structure, in 
line with a helical core and flexible termini. Notably, ssNMR spectra, in 
agreement with FTIR data from the needle, indicate protomer regions 
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red to purple. (c) Solid-state NMR (13C,13C) correlation spectrum of PrgI* in needles (black contours) in comparison with chemical-shift correlations 
corresponding to solution-state NMR assignments (red crosses). Correlations labeled with blue residue codes are unique to solid-state spectra and 
correspond to β-strand backbone structure.






 a, c (Å) 64.53, 104.29
Resolution (Å) 50.00–2.25 (2.31–2.25)a
Rmerge 0.11 (0.92)
I / σI 9.83 (2.11)













 Bond lengths (Å) 0.008
 Bond angles (°) 1.1
One crystal was used.
aValues in parentheses are for highest-resolution shell.
Figure 3 Protomer refolding during assembly of the TTSS needle. (a) X-ray crystal and  
NMR solution structure of PrgI*. Mutated residues (V65A, V67A) and isoleucines are 
highlighted in the X-ray crystal structure. Five C-terminal residues essential for PrgI*  
function are marked in green. Functionally dispensable residues at the N terminus are 
highlighted in red in the NMR structure. (b) Time course of FTIR difference spectra collected 
during polymerization for a period of 28 h. Spectral changes indicate α-helix–to–β-strand 
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residue types alanine, aspartate, isoleucine, leucine, asparagine, serine and 
 threonine (Fig. 3c, blue labels). In particular, the isoleucines, which are 
found within C-terminal residues 71–76 (Fig. 3a) exclusively, show only 
β-strand chemical shifts after needle formation. Except for the described 
β-strand correlations, we found an excellent match between solution- and 
solid-state NMR results (Fig. 3c). A list of possible backbone configura-
tions for all residues in PrgI* is presented in Supplementary Table 1 and 
Supplementary Figure 10.
Multiple unambiguous sequential resonance assignments, derived as 
shown in Supplementary Figure 11 and denoted along the sequence 
in Figure 4a, further facilitated the localization of secondary-structure 
elements. The results point to two β-strands that comprise at least residues 
Ser62–Ala65 and Ile71–Ile76. Both β-strands potentially form a hairpin 
motif involving Lys69 and Asp70 (Fig. 4a,b), where Phe68 would account 
for the extended-strand phenylalanine resonances (Supplementary 
Fig. 12). The central helix-turn-helix motif comprising residues 
Val20–Glu53 is conserved, and possible extension by several residues 
in both directions is consistent with the spectra (Fig. 3c). In particular, 
both glutamates (Glu29 and Glu53) should reside within α-helices, as 
chemical-shift correlations for other secondary-structure elements are 
absent (Supplementary Fig. 12). Although random coil–type chemical 
shifts from solution for N-terminal residues match well with the ssNMR 
spectra, a detailed structural description for this segment remains elusive. 
Notably, chemical shifts for Thr18 and Gly19 suggest a stabilization of the 
α-helix for these two residues relative to solution. We probed a potential 
β-sheet comprising Tyr8 and Leu9 with C-terminal residues, which would 
be compatible with several unassigned tyrosine and leucine correlations, 
by comparing spectra for PrgI* with and without additional Y8A and 
L9A mutations. Based on the high similarity of the spectra, we ruled out 
this possibility (Supplementary Fig. 13). Furthermore, the presence of 
a leucine spin system in INEPT-based spectra that contain only signals 
from flexible protein segments (Supplementary Fig. 14) supports that the 
N terminus is indeed disordered at least up to residue Leu9. We detected 
multiple signal sets, which may be attributed to polymorphism, for threo-
nine and isoleucine, and likewise, spectral overlap could be aggravated 
for other residues. PrgI* chemical-shift characteristics were reproduced 
over all four uniformly labeled samples used in total. In summary, the 
soluble protomer adopts an α-helical hairpin structure that, during needle 
assembly, changes conformation into two extended strands comprising 
approximately the C-terminal 18 residues of PrgI*.
It is noteworthy that mutated residues V65A and potentially V67A as well 
as wild-type residue Ile76 at the C terminus, which was deleted in mutants 
used in previous studies, are part of the β-strand in protomer needles. As 
the β-sheet propensity of valine is higher than that of alanine, it is likely that 
the α-helix–to–β-strand transformation accounts for the formation of the 
 needle. Due to the high sequence similarity of the protomers10 (Supplementary 
Fig. 1), we expect that the C-terminal β-sheet is essential for the TTSS 
needle assembly in various different bacterial pathogens.
DISCUSSION
In summary, we developed a functional and soluble protomer mutant, 
which allowed us to detect important steps in the assembly of TTSS 
needles. The needle protomer adopts an α-helical hairpin-like structure 
before polymerization. This may reflect the protein conformation inside 
the bacterial cytosol (Figs. 3a and 4a,b, state I), which, for some protomer 
homologs, might be trapped by binding specific chaperones19,32–34. As 
shown by previous work, the protomer is mounted by the annular portion 
of the TTSS in a process that involves proteins like PrgJ in S. typhimurium 
forming the central rod of this protein complex20. Notably, we found that 
the TTSS needle itself serves as a polymerization nucleus for the ATP-
independent addition of protomers (Fig. 2). Hence, after the first pro-
tomer molecules are positioned by additional ‘scaffolding’ proteins8,18,20, 
the needle may provide a polymerization platform for arriving protomer 
molecules. In living bacteria, protomer molecules are unfolded in an energy-
dependent process and may be transported24,35,36 through the channel 
formed by the TTSS toward the distal end of the growing needle (Fig. 4b). 
In S. flexneri, the inner needle diameter was determined to be 20–30 Å  
in size. This channel diameter would allow the passage of a folded helix, or 
even a helical hairpin, through the TTSS. The spontaneous polymeriza-
tion (Fig. 3a,b) of protomer into TTSS needles requires a conformational 
change in the C-terminal helix of the protein into a β-sheet conformation 
Table 2 NMR and refinement statistics for monomeric Prgl*
PrgI*
NMR distance and dihedral constraints
Distance constraints
 Total NOE 837
 Intra-residue 262
 Inter-residue 575
  Sequential (|i – j | = 1) 299
  Medium-range (|i − j | < 4) 188
  Long-range (|i − j | > 5) 88
Intermolecular –
Hydrogen bonds –





Violations (mean ± s.d.)
 Distance constraints (Å) 0.03 ± 0.001
 Dihedral angle constraints (°) 0.42 ± 0.035
 Max. dihedral angle violation (°) 4.04
 Max. distance constraint violation (Å) 0.40
Deviations from idealized geometry
 Bond lengths (Å) 0.01
 Bond angles (°) 0.65
 Impropers (°) 0.52
Average pairwise r.m.s. deviationa (Å)
 Heavy 0.83 ± 0.11
 Backbone 0.36 ± 0.14
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Figure 4 Assembly of the TTSS needle. (a) Proposed secondary  
structure of PrgI* before (stage I) polymerization and after (stage II) 
forming needles (α-helix, bar; β-strand, arrow; random coil, line). Hatched 
regions in stage I correspond to secondary structure with higher flexibility. 
For dashed regions in stage II, no unambiguous resonance assignments 
are available. (b) Model of needle constitution. Cytosolic protomer is 
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(Fig. 4a,b, state II). It is noteworthy to compare the assembly of the TTSS 
and the flagellum, which are closely related. It is not known whether 
protomer refolding is required for the assembly of the flagellum35. As the 
flagellum also grows at the tip, it will be rewarding to determine whether 
the structural changes observed here are unique to the TTSS.
The observed conformational changes of the protomer from 
α-helix to partially β-sheet are fundamental for a correct description 
of the TTSS needle structure in the future. Structure determination 
of the protomer in the needle at atomic resolution using solid-state 
NMR is currently in progress in our laboratories. Because assembly 
of the TTSS needle is essential for bacterial virulence, searching for 
substances that inhibit protomer refolding could lead to the discovery 
of a novel target for the development of compounds that specifically 
interfere with pathogenic enterobacteria.
METHODS
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/nsmb/.
Accession codes. Protein Data Bank: Coordinates for PrgI* obtained 
by X-ray crystallography and solution-state NMR have been deposited 
with accession codes 2X9C and 2KV7, respectively.
Note: Supplementary information is available on the Nature Structural & Molecular 
Biology website.
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ONLINE	METHODS
Cloning, gene expression and protein purification. prgI and mxiH were ampli-
fied from S. enterica serovar typhimurium strain SL1344 or S. flexneri strain M90T, 
respectively, by standard PCR using oligonucleotide primers with NdeI and XhoI 
restriction sites at either ends. PCR products were cloned into the expression 
 vector pET-28a(+) (Novagen) containing an N-terminal histidine tag. For func-
tional assays, prgI and mxiH were cloned into the pASK-IBA33(+) vector (IBA) as 
BsaI fragments. N- and C-terminal deletions as well as alanine point mutants were 
generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). All 
constructs were confirmed by sequencing. Protomer mutants were expressed in 
E. coli BL21(DE3) RIL cells harboring the gene in pET-28a(+) expression vector. 
Cells were induced with isopropyl-β-d-1-thiogalactopyranoside and harvested 
after 4 h, and histidine-tagged protein was purified using affinity chromatogra-
phy (HisTrap, GE Healthcare). Bound protein was washed (80 mM imidazole) 
and eluted using buffer containing 500 mM imidazole. After buffer exchange 
(20 mM HEPES, pH 7.4, 50 mM NaCl), the tag was cleaved with the CleanCleave 
Kit (Sigma-Aldrich). The cleaved product was purified by size-exclusion 
chromatography (Superdex 200, GE Healthcare) and stored at 4 °C until use. 
For 15N and/or 13C labeling of PrgI*, M9 minimal medium was complemented 
with [15N]–ammonium chloride and [13C6]-glucose.
Crystallization, data collection, structure determination and refinement. 
Hexagonal crystals of PrgI* were obtained at 18 °C using hanging-drop vapor 
diffusion technique mixing equal volumes of protein and reservoir solution con-
taining 150 mM NH4H2PO4. Crystals of space group P312 (a = b = 64.53 Å, 
c = 104.29 Å, α = β = 90°, γ = 120°) containing two copies of the protein per 
asymmetric unit were flash frozen in liquid nitrogen in the presence of 30% (v/v) 
glycerol. X-ray diffraction data were collected at 100 K and at a wavelength of 
0.97625 Å at the European Synchrotron Radiation Facility (ID 23-1). Data were 
indexed, integrated and scaled using the program package XDS37 and analyzed 
for merohedral twinning using the Padilla-Yeates Algorithm38 and CNS39. The 
crystal structure of PrgI* was solved by molecular replacement with Phaser40 
using MxiH (PDB 2CA5) as a template. The initial model was refined by repeated 
cycles of manual building and refinement using the programs Coot41 and CNS39. 
Ramachandran analysis42 of the X-ray crystal structure of PrgI* showed that 
96.5% of the residues were in their most favored conformations, and the other 
3.5% were in allowed conformations.
Generation of knockout strains. Bacterial knockouts were generated accord-
ing to previous work43. pASK-IBA(+) plasmids harboring wild-type or mutant 
prgI (pprgI) or mxiH (pmxiH) were used to complement deletions of prgI in 
S. typhimurium strain SL1344 and mxiH in S. flexneri to generate strains SL1344 
ΔprgI/pprgI and M90T ΔmxiH/pmxiH, respectively.
HeLa cell invasion assay. HeLa cells were seeded at 1 × 105 cells per well and 
grown for 24 h at 37 °C. Prior to infection, growth medium was aspirated, cells 
were washed twice with PBS and serum-free medium was added. To test for 
epithelial cell invasion and intracellular growth, HeLa cells were infected with 
S. typhimurium at a multiplicity of infection of 10:1. Expression of prgI and mxiH 
was induced with 0.2 μg ml−1 anhydrotetracycline for 1 h. Bacterial inocula were 
prepared in PBS and centrifuged onto cells (700g, 10 min), and infected cultures 
were incubated for 20 min at 37 °C. Cultures were washed three times with PBS, 
and fresh medium containing 100 μg ml−1 gentamicin was added. After 2 h, cells 
were washed with PBS and lysed with 0.1% (w/v) Triton X-100. Numbers of viable 
bacteria were obtained by plating dilutions of lysates on tryptic soy agar plates 
and counting colonies after overnight (16 h) incubation at 37 °C.
Isolation of the needle complex. Needle complex from S. typhimurium or 
S. flexneri was extracted and purified according to a modified protocol described 
previously44 (Xiang et al., personal communication). Each needle complex con-
sists of a membrane-embedded base and an extracellular needle-shaped structure 
with a typical length of 50–70 nm.
Analytical ultracentrifugation. Analytical ultracentrifugation sedimentation 
velocity experiments were performed in an XL-I Analytical Ultracentrifuge 
(BeckmanCoulter) using the interference optics of the instrument. Freshly puri-
fied PrgI* (1.0 mg ml−1) was measured at 4 °C and 116,480g (BeckmanCoulter 
An-50Ti rotor) in the presence of 20 mM HEPES, pH 7.5, 50 mM NaCl 
(Nanolytics). Data were analyzed with the program NONLIN (http://www. 
biotech.uconn.edu/auf/?i=aufftp).
Solution-state NMR data acquisition and processing. NMR spectra were 
acquired at 14.1, 18.8 and 21.1 T on Bruker Avance spectrometers (Bruker 
AG, Karlsruhe, Germany) at 283 K with samples containing ~0.3 mM PrgI* in 
20 mM MES, pH 5.5, and 20 mM NaCl buffer in the presence of 93% (v/v) 
H2O/7% (v/v) 2H2O. Freshly purified protein at low concentration (0.3 mM) 
was used to delay polymerization. Spectral patterns did not change during the 
acquisition of NMR spectra. The anisotropic sample for extraction of 36 RDCs 
was prepared by addition of 18 mg ml−1 pf1 phages as alignment medium to the 
NMR sample. Data were processed with NMRPipe45 and analyzed with CARA46. 
Ramachandran analysis of the NMR structure of PrgI* showed that 84.2% of the 
residues were in their most favored conformations, and the other 15.8% were in 
allowed conformations.
Sequential/side chain assignment. Sequential assignments of PrgI* were 
 accomplished by a combination of (1H-15N)-HSQC47,48, (1H-13C)-HSQC49, 
HNCACB50, HNCA51, CBCA(CO)NH52, HNCO53, (H)CCH-COSY and 
(H)CCH-TOCSY54. Aromatic resonance assignments were made using the 
(1H-1H-15N) and (1H-1H-13C) 3D NOESY spectra. (1H-15N)-RDCs were deter-
mined from resonance splitting in (1H-15N) TROSY-HSQC55 and (1H-15N) 
COCAINE spectra56 (modified version) in isotropic and anisotropic samples.
Electron microscopy. Sample solutions were applied to glow-discharged carbon-
coated copper grids, incubated for 2 min, washed and contrasted with 4% (w/v) 
PTA for 1 min. Specimens were examined with a Leo912 AB (Zeiss SMT) trans-
mission electron microscope equipped with a side-mounted Cantega digital 
camera (Olympus SIS).
Dynamic light scattering. Measurements were carried out using a Malvern 
Instruments particle sizer (Zetasizer Nano ZS, Malvern Instruments) equipped 
with a He-Ne laser (λ = 632.8 nm). DLS was performed at 25 °C in backscattering 
modus at a scattering angle of 2θ = 173° with 10 mm × 10 mm quartz cuvettes. 
Prior to measurement, the sample was filtered with a 0.45-μm syringe filter 
(Millipore). The Stokes-Einstein relation was used to calculate the hydrodynamic 
radius (Malvern Dispersion Technology Software 5.02).
Solid-state NMR. Multidimensional solid-state NMR correlation spectra57,58 
were recorded at 18.8 and 20.0 T with Bruker Avance II/III spectrometers using 
10–15 mg PrgI* (see Supplementary Methods for details).
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